Streetbeat News

Stock Prices

VIEW

View Inc.'s shares are trading lower due to potential market weakness following the company's announcement of filing for Chapter 11 bankruptcy.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:22 pm

ALCE

Alternus Clean Energy Inc (NASDAQ:ALCE) shares surged after announcing a joint venture with Acadia Energy to co-develop 200 MW of Sustainability Hub microgrid projects in New York State. The partnership aims to leverage both companies' strengths in renewable energy, with Alternus holding a 51% majority stake. The projects are expected to start operations within two years, contributing to local economic growth and sustainability.

Portfolio Pulse from Shivani Kumaresan

April 04, 2024 | 4:20 pm

NVS

Novartis shares are trading higher following the company's announcement to file for Pluvicto pre-taxane label expansion in H2 2024, based on positive Phase III PSMAfore study results.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:18 pm

LRCX

Benzinga's options scanner revealed significant activity in Lam Research (NASDAQ:LRCX) options, with a mix of bullish and bearish sentiments among big-money investors. The observed options trades suggest a target price range for LRCX between $700 and $1020. Lam Research, a leading semiconductor equipment manufacturer, has seen its stock price increase by 1.6%, with a current price of $994.01. Analyst ratings from Wells Fargo and Cantor Fitzgerald indicate a cautious outlook, with target prices of $980 and $900, respectively.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 4:16 pm

DT

Dynatrace (NYSE:DT) has seen a significant surge in options activity, with a bullish sentiment from big-money investors. Benzinga's options scanner revealed 9 notable trades, with a split of 77% bullish and 22% bearish sentiment. The activity targets a price range of $35.0 to $50.0 for DT over the next 3 months. This unusual volume and open interest in options may indicate insider knowledge or expectations of future price movements. Dynatrace, a cloud-native company, is currently trading at $45.01, with an anticipated earnings release in 41 days.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 4:16 pm

VUZI

Vuzix shares are trading higher following the announcement of receiving new additional orders from two aerospace and defense firms for the development and delivery of waveguide-based display solutions in 2024.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:09 pm

DIS

Disney CEO Bob Iger discussed the company's victory in its proxy battle against activist investors, emphasizing the distraction it caused and his relief over the outcome. Iger criticized Nelson Peltz for not bringing new ideas and potentially being a destructive presence on the board. The engagement during the proxy battle highlighted shared priorities among Disney's board, executives, and shareholders. Iger's focus will now return to core business priorities, including film quality, streaming profitability, ESPN's future, and the growth of Disney parks and resorts. Disney shares were up 0.73% at $119.85 following the news.

Portfolio Pulse from Erica Kollmann

April 04, 2024 | 4:07 pm

DASH

LOW

UBER

DoorDash Inc (NASDAQ:DASH) is expanding into the home improvement market through a partnership with Lowe's Companies Inc (NYSE:LOW), as highlighted by Benchmark analyst Mark Zgutowicz. Zgutowicz is bullish on DoorDash, initiating coverage with a Buy rating and a $165 price target, citing strong monetization potential in new verticals like grocery and convenience. The analysis points out DoorDash's significant market share advantage over Uber Technologies Inc's (NYSE:UBER) Uber Eats and its untapped potential in Retail Media advertising. Shares of DoorDash rose by 0.59% to $139.60.

Portfolio Pulse from Priya Nigam

April 04, 2024 | 4:05 pm

PBR

Petrobras shares are trading higher following an agreement between Brazilian ministers for the company to pay extraordinary dividends. This development is seen as a positive move for shareholders, potentially increasing the stock's attractiveness.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:02 pm

VVOS

Vivos Therapeutics' shares surged following the announcement of a notice of allowance for its U.S. patent application for a device aimed at treating sleep disordered breathing, sleep apnea, and snoring.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 4:01 pm